A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
DRUG

arimoclomol

Trial Locations (10)

13210

SUNY Upstate Medical University, Syracuse

17033

Penn State Milton S. Hershey Medical Center, Hershey

19107

Drexel University College of Medicine, Philadelphia

27705

Duke University, Durham

33136

University of Miami School of Medicine, Miami

55404

Hennepin Faculty Associates/Berman Center, Minneapolis

66160

University of Kansas Medical Center, Kansas City

78229

University of Texas Health Science Center at San Antonio, San Antonio

92868

University of California, Irvine Medical Center, Irvine

02129

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CytRx

INDUSTRY